Search Results for "Stiefel Laboratories In Coral Gables"
Original Source: Sodium Sulfacetamide and Sulfur [Perrigo New York Inc]
SODIUM SULFACETAMIDE 10% AND SULFUR 5% LOTION
Matching Channels
The 11th largest pharmaceutical company in the world, Abbott Laboratories generated sales of $16 billion in 2009 and has 90,000 employees. Within the medical device arm of the company, products of...
The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...
The Top 10 Medical Device Companies
Medical devices are crucial to the process of diagnosis and treatment in modern medicine. Sales in this field reach billions of dollar a year, with Johnson & Johnson making $30 billion alone in...
The Top 100 Pharmaceutical Companies
The Top 100 Pharmaceutical Companies, determined by total sales in 2011 - see below for 2010 and 2009: They are listed in descending order with the sales in 2011 in $ million; Pfizer ...
Sequencing platforms in diagnostic laboratories may aid both patient management by detecting resistance associated mutations, and public health measures, by determining phylogenetic relationships be...
Matching News
BH3 Presents 1805 Ponce: The Ideal Opportunity for Cosmopolitan Lifestyles in Coral Gables
CORAL GABLES, Fla., Feb. 21, 2013 (GLOBE NEWSWIRE) -- Adding to its significant portfolio of distinctive South Florida residential and mixed-use condominium properties, BH3 proudly announces its acqu...
BRIEF-Stiefel announces new dosage for Duac
LONDON, March 4 (Reuters) - Stiefel: * Stiefel announces a new, alternate, fixed-dose combination of duac gains
VANCOUVER, July 31, 2012 /CNW/ - Welichem Biotech Inc. ("Welichem" or the "Company" TSX.V: WBI) announces that Welichem and Stiefel, a GSK company, have completed the acquisition by Stiefel of the exc...
GSK’s Stiefel Adds Psoriasis/Atopical Dermatitis Candidate In Licensing Deal
For about $34 million, Stiefel gets development and commercialization rights in most of the world to a novel, non-steroidal, topical anti-inflammatory compound in Phase II.
Stiefel, Basilea sign agreement for Toctino
Basilea Pharmaceutical has signed a global agreement with Stiefel , a GSK company, for Toctino (alitretinoin).
Ecology: Contemplating a coral comeback
The Great Barrier Reef (pictured) has lost about half its coral over the past 27 years, according to data from more than 2,000 surveys of 214 reefs. But addressing local threats could tip the balance...
'We can still save our reefs:' Coral scientist
(ARC Centre of Excellence in Coral Reef Studies) John Pandolfi keeps his optimism alive despite the grim scientific evidence he confronts daily that the world's coral reefs are in a lot of trouble - a...
Dr. Hoover of Coral Gables, FL has been named a Patients' Choice Award Winner for 2012
CORAL GABLES, Fla., April 3, 2013 /PRNewswire-USNewswire/ -- Among the select few physicians honored with the prestigious Patients' Choice Award this year is Dr. Keila Hoover. (Photo: http://photos.p...
Matching PubMed Articles
Retrospective. Bernadine Healy (1944-2011).
The Biology and Economics of Coral Growth.
To protect natural coral reefs, it is of utmost importance to understand how the growth of the main reef-building organisms-the zooxanthellate scleractinian corals-is controlled. Understanding coral g...
The triazole antifungal pramiconazole (Stiefel, a GSK company) was compared with itraconazole, miconazole and terbinafine in vitro and in vivo. A potent in vitro activity against Candida spp. (IC50 0....
Tissue-specific alternative splicing is a key mechanism for generating tissue-specific proteomic diversity in eukaryotes. Splicing regulatory elements (SREs) in pre-mature messenger RNA play a very im...
Editorial for International Journal of Behavioral Medicine: Special Issue on Cancer.
